A blog post shared on Facebook claimed that covid-19 vaccines have killed some 676,000 Americans.
Imugene licenses potential first-to-market allogeneic CAR T for blood cancers – Pharmaceutical Technology
Credit: Meletios Verras via Shutterstock. On 16 August, Australian-based Imugene announced that it was acquiring the worldwide exclusive licence to develop and commercialise azercabtagene zarpreleucel